Leave your feedback Share Copy URL https://ar-c.org/video/ju67sEJCdMI.html Email Facebook Twitter LinkedIn Pinterest Tumblr Share on Facebook Share on Twitter FDA refuses to review Modernas mRNA flu vaccine [9DZxXQyr6zJ] Health Updated on August 07, 2026 EDT — Published on August 07, 2026 EDT The Food and Drug Administration rejected Moderna’s application for its mRNA-based flu vaccine, the drugmaker said Tuesday. The move is the latest sign that the FDA, under Health Secretary Robert F. Kennedy Jr., is slow-walking vaccine approvals and taking a harder line on shots that use messenger RNA technology. Moderna President Stephen Hoge discusses. MS NOW: My Source for News, Opinion, and the World. Same mission. New name. » Subscribe to MS NOW: MS NOW is the go-to destination for domestic and international breaking news, and best-in-class opinion journalism. For more context and news coverage of the most important stories of our day click here: #FDA #RFKJr #Vaccine nHWb7bZOOXU 9mw5sB9RGIe LQaB7mtVsMO XGfbIo52fXL
The Food and Drug Administration rejected Moderna’s application for its mRNA-based flu vaccine, the drugmaker said Tuesday. The move is the latest sign that the FDA, under Health Secretary Robert F. Kennedy Jr., is slow-walking vaccine approvals and taking a harder line on shots that use messenger RNA technology. Moderna President Stephen Hoge discusses. MS NOW: My Source for News, Opinion, and the World. Same mission. New name. » Subscribe to MS NOW: MS NOW is the go-to destination for domestic and international breaking news, and best-in-class opinion journalism. For more context and news coverage of the most important stories of our day click here: #FDA #RFKJr #Vaccine nHWb7bZOOXU 9mw5sB9RGIe LQaB7mtVsMO XGfbIo52fXL